| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Michael J Burke, Jana Lincol. Aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 18. issue 2. 2006-08-24. PMID:16754419. |
aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist. |
2006-08-24 |
2023-08-12 |
Not clear |
| Anders Fredriksson, Trevor Arche. Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice. Neurotoxicity research. vol 9. issue 4. 2006-08-23. PMID:16782590. |
in the context of these and other observations, it is suggested that subchronic administration of haloperidol interacting with postnatal iron induces different expressions of dopamine neuron comorbidity underlying movement disorder. |
2006-08-23 |
2023-08-12 |
mouse |
| M A Cheĭdo, G V Idov. [Differential contribution of dopamine D1 and D2 receptors in the mu-opioidergic immunomodulation]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova. vol 92. issue 5. 2006-08-18. PMID:16869283. |
haloperidol (2 mg/kg), a selective antagonist of the postsynaptic dopamine (da) receptors, prevented immunostimulating effect of dago. |
2006-08-18 |
2023-08-12 |
mouse |
| G V Idova, M A Cheĭdo, E N Zhukov. [Effect of the activation and blockade of D2 dopamine receptors on the immune response in mice with different types of social behavior]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova. vol 92. issue 5. 2006-08-18. PMID:16869284. |
at the same time, the blockade of d2 dopamine receptors with haloperidol suppressed immunogenesis in aggressive and control mice, whereas the immune reactions in submissive mice were unchanged. |
2006-08-18 |
2023-08-12 |
mouse |
| Seth Y Ablordeppey, Margaret Lyles-Eggleston, Barbara Bricker, Wang Zhang, Xue Zhu, Carl Goodman, Bryan L Rot. Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidol. Bioorganic & medicinal chemistry letters. vol 16. issue 12. 2006-08-16. PMID:16621538. |
enantiomeric separation of the racemic 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, a pyrrolidine analog of haloperidol, {(+/-)-sya 09}, and subsequent binding studies revealed that most of the binding affinity at dopamine and serotonin receptors resides in the (+)-isomer {(+)-sya 09} or the eutomer. |
2006-08-16 |
2023-08-12 |
rat |
| Omar M E Abdel-Sala. Antinociceptive and behavioral effects of ribavirin in mice. Pharmacology, biochemistry, and behavior. vol 83. issue 2. 2006-08-14. PMID:16563475. |
further, the ribavirin induced antinociception was enhanced by d2 receptor antagonists haloperidol, sulpiride, clozapine or domperidone and by the dopamine d2 receptor agonist bromocryptine. |
2006-08-14 |
2023-08-12 |
mouse |
| Q David Walker, Rupa Ray, Cynthia M Kuh. Sex differences in neurochemical effects of dopaminergic drugs in rat striatum. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 31. issue 6. 2006-08-07. PMID:16237396. |
the typical antipsychotic, haloperidol, increased dopamine efflux in both sexes but the effect was twice as large in the female striatum. |
2006-08-07 |
2023-08-12 |
rat |
| Filomena Mattner, Karine Mardon, Christian Loc'h, Andrew Katsifi. Pharmacological evaluation of an [(123)I] labelled imidazopyridine-3-acetamide for the study of benzodiazepine receptors. Life sciences. vol 79. issue 3. 2006-08-04. PMID:16464478. |
flumazenil, a central benzodiazepine drug and haloperidol (dopamine antagonist/sigma receptor drug) displayed no effect in [(123)i]izol in peripheral organs and in the brain. |
2006-08-04 |
2023-08-12 |
rat |
| Glenn W Stevenson, Edward J Bilsky, S Stevens Negu. Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. The journal of pain. vol 7. issue 6. 2006-07-27. PMID:16750797. |
morphine (1 mg/kg) prevented both acid-induced writhing and acid-induced suppression of feeding, whereas the dopamine antagonist haloperidol inhibited writhing without preventing acid-induced suppression of feeding. |
2006-07-27 |
2023-08-12 |
mouse |
| Ewa Obuchowicz, Zbigniew S Herma. Lack of effect of some dopamine and non-dopamine receptor ligands on amphetamine-induced changes in the rat brain neuropeptide Y system. Pharmacological reports : PR. vol 57. issue 6. 2006-07-21. PMID:16382207. |
none of the receptor ligands studied: the dopamine d2 antagonist eticlopride, d2/d3 antagonist haloperidol, alpha1-adrenergic antagonist prazosin, n-methyl-d-aspartate antagonist mk-801, 5-ht2/d2 antagonist mianserin, d2/d3 agonist quinpirole and alpha2-adrenergic agonist clonidine co-administrated with repeated amphetamine (amph) injections blocked the amph-induced decrease in the striatal and nucleus accumbens neuropeptide y (npy) levels. |
2006-07-21 |
2023-08-12 |
rat |
| L Fontana, A S Souza, E A Del Bel, R M W de Oliveir. Ginkgo biloba leaf extract (EGb 761) enhances catalepsy induced by haloperidol and L-nitroarginine in mice. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 38. issue 11. 2006-07-10. PMID:16258634. |
l g-nitro-arginine (l-noarg), a nitric oxide synthase inhibitor, and haloperidol, a drug that blocks dopamine receptors, are both known to induce catalepsy in rodents. |
2006-07-10 |
2023-08-12 |
mouse |
| Cristina Cosi, Elisabeth Carilla-Durand, Marie Bernadette Assié, Anne Marie Ormiere, Mireille Maraval, Nathalie Leduc, Adrian Newman-Tancred. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. European journal of pharmacology. vol 535. issue 1-3. 2006-06-21. PMID:16554049. |
we compared the effects of the new antipsychotic agents ssr181507 ((3-exo)-8-benzoyl-n-[[(2 s)7-chloro-2,3-dihydro-1,4-benzodioxin-1-yl]methyl]-8-azabicyclo[3.2.1]octane-3-methanamine monohydrochloride), bifeprunox (du127090: 1-(2-oxo-benzoxazolin-7-yl)-4-(3-biphenyl)methylpiperazinemesylate) and slv313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4-[5-(4-fluorophenyl)-pyridin-3-ylmethyl]-piperazine) with those of aripiprazole (7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]-butyloxy)-3,4-dihydro-2(1 h)-quinolinone), clozapine and haloperidol, on functional measures of dopamine d2 receptor activity in vitro and in vivo: [35s]-gtpgammas binding to membranes from sf9 insect cells expressing human dopamine d2 long (hd2 l) receptors, and serum prolactin levels in the rat. |
2006-06-21 |
2023-08-12 |
human |
| Claire Roberts, Robert Cummins, Zaira Gnoffo, James N C Ke. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens. European journal of pharmacology. vol 534. issue 1-3. 2006-06-07. PMID:16490190. |
clozapine, haloperidol, sulpiride and the selective dopamine d3 receptor antagonist, sb-277011-a, had no effect on dopamine efflux per se but all attenuated the (+/-)7-oh-dpat-induced-inhibition of dopamine efflux, with pa2 values of 6.6, 7.9, 7.0 and 7.6, respectively. |
2006-06-07 |
2023-08-12 |
rat |
| Claire Roberts, Robert Cummins, Zaira Gnoffo, James N C Ke. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens. European journal of pharmacology. vol 534. issue 1-3. 2006-06-07. PMID:16490190. |
in contrast, haloperidol and sulpiride significantly increased dopamine efflux through a d2 receptor-mediated mechanism. |
2006-06-07 |
2023-08-12 |
rat |
| Juan Bustillo, Ranee Barrow, Rodrigo Paz, Jennifer Tang, Navid Seraji-Bozorgzad, Gregory J Moore, Federico Bolognani, John Lauriello, Nora Perrone-Bizzozero, Matthew P Gallowa. Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 31. issue 4. 2006-05-25. PMID:16132064. |
a prolonged exposure to the dopamine d2 receptor blockade effects of haloperidol does not result in changes in naa, glutamate, glutamine, and other metabolites in the proton spectrum. |
2006-05-25 |
2023-08-12 |
rat |
| Kotaro Hattori, Shigeo Uchino, Tomoko Isosaka, Mamiko Maekawa, Masaomi Iyo, Toshio Sato, Shinichi Kohsaka, Takeshi Yagi, Shigeki Yuas. Fyn is required for haloperidol-induced catalepsy in mice. The Journal of biological chemistry. vol 281. issue 11. 2006-05-10. PMID:16407246. |
expression of the striatal dopamine d(2) receptor, the main site of haloperidol action, did not differ between the two genotypes. |
2006-05-10 |
2023-08-12 |
mouse |
| Nadine Kabbani, Robert Levenso. Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex. Neuroreport. vol 17. issue 3. 2006-05-09. PMID:16462601. |
here, we examined the effects of chronic haloperidol and clozapine on cortical d2 dopamine receptors and six different dopamine receptor interacting proteins. |
2006-05-09 |
2023-08-12 |
Not clear |
| Nadine Kabbani, Robert Levenso. Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex. Neuroreport. vol 17. issue 3. 2006-05-09. PMID:16462601. |
using comparative immunoblot analysis, we found that treatment with either haloperidol or clozapine increased d2 dopamine receptors, calcium activator protein for secretion, protein 4.1n, and neuronal calcium sensor-1 expression. |
2006-05-09 |
2023-08-12 |
Not clear |
| Sanna Janhunen, Paula Mielikäinen, Päivi Paldánius, Raimo K Tuominen, Liisa Ahtee, Seppo Kaakkol. The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats. Naunyn-Schmiedeberg's archives of pharmacology. vol 371. issue 6. 2006-04-28. PMID:16012872. |
we used brain microdialysis to study the effects of nicotine on extracellular levels of dopamine (da) and its metabolites in the rat dorsal striatum in combination with drugs inhibiting either da uptake (nomifensine), catechol-o-methyltransferase (comt; tolcapone), monoamine oxidase b (mao-b; selegiline) or da receptors (haloperidol). |
2006-04-28 |
2023-08-12 |
rat |
| Carsten Saft, Thorsten Lauter, Peter H Kraus, Horst Przuntek, Juergen E Andric. Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series. BMC neurology. vol 6. 2006-04-28. PMID:16507108. |
chorea in huntington's disease (hd) is usually treated with antidopaminergic neuroleptics like haloperidol, olanzapine and tiaprid or dopamine depleting drugs like tetrabenazine. |
2006-04-28 |
2023-08-12 |
Not clear |